News

Clinical Trials Arena on MSN2d
PYC Therapeutics to begin Part B in SAD trial for polycystic kidney disease
P YC Therapeutics is set to begin Part B in its single ascending dose (SAD) study of the drug candidate, PYC-003, for ...
Johns Hopkins Medicine5d
Polycystic Kidney Disease - Johns Hopkins Medicine
What is polycystic kidney disease? Polycystic kidney disease (PKD) is a genetic condition marked by the growth of numerous cysts (fluid-filled sacs) in the kidneys. The cysts become larger and the ...